SONX
Sonendo, Inc.
OTC Markets OTCPK · CIK 1407973
Last close0.85
Daily change+0.05 (6.25%)
10 Years gain-99.95%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
SONX · STANDARD
SIC 3843 · Dental Equipment & Supplies · Fiscal year end 1231
Fundamental
29.2Momentum
100.0Acceleration
60.0Confidence
86.0Annual Revenue8
Quarterly Revenue13
Annual CFO5
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality6.8 / 25
Capital Efficiency0.0 / 20
Balance Sheet12.4 / 15
Shareholder Economics5.0 / 10
Forward Indicators5.0 / 5
Signals
Gross margin expansionGross margin improved by 12.6817 percentage points.
Operating leverageOperating margin improved by 34.363 percentage points.
Share count reductionDiluted share count declined 99.4899%.
Warnings
Negative FCF · HIGHLatest free cash flow is negative.
High SBC · MEDIUMStock based compensation is high relative to revenue or FCF.
ROIC declining · MEDIUMROIC declined by 48.5964 percentage points.
Key Metrics
Revenue Growth TTM-16.58%OK
Revenue CAGR 3Y-8.66%OK
Gross Margin29.5%OK
Operating Margin-127.67%OK
FCF Margin-102.38%OK
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-124.33%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFO-0.02xOK
Diluted Share Growth 1Y-99.49%OK
SBC / Revenue19.03%OK
SBC / FCF-18.59%OK
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 FY Dec 31, 2024 | $31.70M | $11.84M | -$29.37M | -$24.65M | -$24.81M | 37.35% | -92.63% | -78.27% | n/a | 474,856 |
| 2024 FY Sep 30, 2024 | $36.50M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| 2024 FY Jun 30, 2024 | $38.90M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| 2024 FY Mar 31, 2024 | $41.60M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| 2024 FY Dec 31, 2023 | $34.63M | $4.67M | -$59.27M | -$46.06M | -$46.99M | 13.48% | -171.15% | -135.7% | -179.58% | 469,943 |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $31.56M | sum latest 4 fiscal quarters Revenue | OK | 0000950170-24-125447, 0000950170-24-055662 |
| Revenue Growth TTM | -16.58% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000950170-24-125447, 0000950170-24-055662 |
| Revenue CAGR 3Y | -8.66% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000950170-25-045214 |
| Revenue CAGR 5Y | -5.31% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000950170-25-045214 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0000950170-25-045214 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0000950170-24-125447, 0000950170-24-055662 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | 0000950170-24-125447, 0000950170-24-092787 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 29.5% | Gross Profit / Revenue | OK | 0000950170-24-125447, 0000950170-24-055662 |
| Operating Margin | -127.67% | Operating Income / Revenue | OK | 0000950170-24-125447, 0000950170-24-055662 |
| FCF Margin | -102.38% | (CFO - CapEx) / Revenue | OK | 0000950170-24-125447, 0000950170-24-092787 |
| ROIC | -124.33% | NOPAT / Average Invested Capital | OK | 0000950170-24-125447, 0000950170-24-055662 |
| Net Debt / CFO | -0.02x | Net Debt / CFO | OK | 0000950170-24-125447, 0000950170-24-092787 |
| Current Ratio | 1.82x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.97x | (Cash + Short-term Investments) / Total Debt | OK | 0000950170-24-125447 |